ITULATEK
ALK-Abelló A/S
Application Filed: 2018-04-20
Trademark Application Details
SUSPENSION INQUIRY - MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87886775 |
| Registration Number | 6115768 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Monica Riva Talley |
| Attorney Docket Number | 3985.0060000 |
| Law Office Assigned | L50 |
| Employee Name | KUNKLEMAN, SARAH E |
Timeline
| 2018-04-20 | Application Filed |
| 2019-09-27 | Location: TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED |
| 2019-09-27 | Status: Live/Pending |
| 2019-09-27 | Transaction Date |
| 2020-08-04 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  ALK-Abelló A/S |
| Entity Statement | public limited company |
| Address | Bøge Allé 6-8 Hørsholm DK DK-2970 |
| Legal Entity Type | |
| Legal Entity State | DK |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; diagnostic preparations for medical purposes, diagnostic reagents for medical use and diagnostic testing materials for medical use, pharmaceutical preparations in the form of injectable pharmaceuticals |
| GS0051 | Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes in relation to allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis and respiratory allergic diseases, and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; diagnostic preparations for medical purposes, namely, for the treatment, monitoring and diagnosing of allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, diagnostic reagents and diagnostic testing materials being medical diagnostic test strips, diagnostic test patch for application to the skin for determining allergies, medical diagnostic test media in the form of test strips, all for medical use in diagnosing, preventing and treating allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-04-24 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-05-01 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-08-09 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-08-16 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-08-16 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-08-16 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-02-19 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-02-19 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-02-20 | 9 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2019-03-06 | 10 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2019-03-06 | 11 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-03-06 | 12 GNS3 O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2019-09-26 | 13 ALIE A:Allowance for Publication |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2019-09-27 | 14 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2019-09-27 | 15 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2019-09-27 | 16 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2019-09-27 | 17 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2020-03-25 | 18 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-03-26 | 19 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-03-26 | 20 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2020-04-10 | 21 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2020-04-10 | 22 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-04-10 | 23 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2020-04-10 | 24 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-04-10 | 25 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-04-29 | 26 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2020-05-19 | 27 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-05-19 | 28 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-08-04 | 29 R.PR A:Allowance for Publication |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 